ArTara Therapeutics Inc (TARA)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

1 LITTLE WEST 12TH STREET NEW YORK, NY 10014

Proteon Therapeutics, Inc. researches and develops biopharmaceutical products. The Company produces pharmaceuticals to address the medical needs of patients with renal and vascular diseases.

Data as of 2020-08-01
Market Cap145.729 Million Shares Outstanding5.843 Million Avg 30-day Volume36.661 Thousand
P/E Ratio Dividend Yield EPS-7.82
Price/Sales Price cash flow ratio Price free cash flow ratio
Book Value8.88 Price to Tangible Book3.92 Alpha-0.0
Short Interest Ratio % Short Interest to Float R-squared0.019429
BETA1.03649 52-week High/Low67.079 / 8.8 Stddev0.31993
View SEC Filings from TARA instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 1 1 (0.07%)
13F Filers holding this stock: 29 10 (0.65%)
Aggregate 13F shares on 03/31/2020: 3.953 Million 3.006 Million
Aggregate 13F shares on 12/31/2019: 169.284 Thousand 92.346 Thousand
Percent change: 2235.39% 3154.82%
Funds creating new positions: 17 5
Funds Adding to an existing position: 10 4
Funds closing out their position: 5 3
Funds reducing their position: 1 1
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding TARA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TARA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

42.8 Thousand total shares from 23 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MARSHALL RANDALL

  • 10% Owner
611,180 2020-07-29 8

FLANNELLY BARRY P

  • Director
0 2020-07-23 2

KINGSLEY STUART A PRESIDENT AND CEO

  • Officer
  • Director
0 2020-07-16 0

SHEFFERMAN JESSE CEO AND PRESIDENT

  • Officer
  • Director
0 2020-07-10 4

HASTINGS PAUL J SEE REMARKS

  • Officer
  • Director
253,061 2020-07-09 0

LEVY RICHARD S

  • Director
0 2020-06-30 3

ABINGWORTH LLP

  • 10% Owner
10,302,602 2020-06-26 1

CANUTE SCOTT A

  • Director
17,234 2020-06-18 0

FREUND JOHN GORDON

2,828,782 2020-06-16 1

BESHAR LUKE M

  • Director
0 2020-06-09 4

BRAUNSTEIN SCOTT

  • Director
0 2020-06-09 4

SARGEN GREGORY

  • Director
0 2020-06-09 3

GARCEAU ROGER

  • Director
0 2020-06-09 4

SOLOMON MICHAEL EDWARD

  • Director
0 2020-06-09 4

LEFF JONATHAN S

  • Director
0 2020-05-28 0

BOHLIN GAREN G

  • Director
0 2020-05-21 0

BURKE STEVEN KEITH SVP, CHIEF MEDICAL OFFICER

99,000 2020-02-28 0

DAVIS BLAINE CHIEF FINANCIAL OFFICER

  • Officer
0 2020-02-11 2

OPALEYE, L.P.

  • 10% Owner
2,208,472 2020-01-09 2

ZUMMO JACQUELINE SR. VICE PRESIDENT, RESEARCH

  • Officer
74,113 2020-01-09 2

CASOY JULIO CHIEF MEDICAL OFFICER

  • Officer
45,500 2020-01-09 2

HAINES TIMOTHY

  • FORMER DIRECTOR AND 10% OWNER
2,144,517 2019-11-12 1

FLYNN JAMES E

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

  • Director
  • 10% Owner
  • *DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION
0 2019-06-06 0

NOYES TIMOTHY P PRESIDENT AND CEO

  • Officer
  • Director
0 2019-01-31 0

ELDRIDGE, GEORGE ARTHUR SR VP, CFO, TREASR, ASST SECY

  • Officer
0 2019-01-18 0

GOTTLIEB DANIEL PHILIP VP CORPORATE DEVELOPMENT

  • Officer
0 2019-01-18 0

TONER E. SCOTT SENIOR VP OF COMMERCIAL

  • Officer
0 2019-01-18 0

KOWALSKY MATTHEW PAUL VP, LEGAL AND SECRETARY

  • Officer
0 2019-01-18 0

HARTMAN BRADLEY J VP, PEOPLE

  • Officer
0 2019-01-18 0

BIRNER HUBERT

  • Director
  • 10% Owner
0 2018-06-08 0

FLYNN JAMES E

DEERFIELD MANAGEMENT CO

DEERFIELD MGMT L.P.

DEERFIELD PARTNERS, L.P.

DEERFIELD INTERNATIONAL MASTER FUND, L.P.

  • Director
  • 10% Owner
  • *DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION
1,224,899 2017-11-30 0

PHARMSTANDARD INTERNATIONAL S.A.

JOINT STOCK CO PHARMSTANDARD

  • 10% Owner
13,142,784 2017-10-31 0

FLYNN JAMES E

DEERFIELD PRIVATE DESIGN FUND III, L.P.

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD INTERNATIONAL MASTER FUND, L.P.

DEERFIELD PARTNERS, L.P.

DEERFIELD PRIVATE DESIGN FUND IV, L.P.

DEERFIELD MGMT L.P.

DEERFIELD MGMT III, L.P.

DEERFIELD MGMT IV, L.P.

DEERFIELD MANAGEMENT CO

  • Director
  • *DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION
1,224,899 2017-08-02 0

TVM LIFE SCIENCE VENTURES VI GMBH & CO KG

TVM LIFE SCIENCE VENTURES VI LP

BIRNER HUBERT

FISCHER STEFAN

SCHUHSLER HELMUT

  • Director
  • 10% Owner
0 2017-06-22 0

O'LEARY BRENDAN

  • Director
0 2016-06-09 0

PHELPS GREGORY D

  • Director
0 2015-06-02 0

KOBYZEV DMITRY

  • Director
  • 10% Owner
0 2015-06-02 0

SKYLINE VENTURE PARTNERS QUALIFIED PURCHASER FUND IV L P

SKYLINE VENTURE MANAGEMENT IV, LLC

FREUND JOHN GORDON

KANEKO YASUNORI

  • 10% Owner
1,432,930 2014-10-27 0

TVM LIFE SCIENCE VENTURES VI GMBH & CO KG

FISCHER STEFAN

GOLL ALEXANDRA

SCHUHSLER HELMUT

TVM LIFE SCIENCE VENTURES VI LP

  • 10% Owner
3,846,186 2014-10-27 0

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MANAGEMENT CO

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD SPECIAL SITUATIONS INTERNATIONAL MASTER FUND, L.P.

DEERFIELD MGMT III, L.P.

DEERFIELD PRIVATE DESIGN FUND III, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
No longer subject to file 2014-10-27 0

PRISM VENTURE PARTNERS V L P

PRISM VENTURE PARTNERS V-A LP

  • 10% Owner
No longer subject to file 2014-10-27 0

PRISM VENTURE PARTNERS V L P

  • Director
  • 10% Owner
0 2014-10-21 0

PRISM VENTURE PARTNERS V L P

O'LEARY BRENDAN

PRISM VENTURE PARTNERS V-A LP

  • Director
  • 10% Owner
0 2014-10-21 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

MARSHALL RANDALL - > 10% Owner

2020-07-30 S 1,317 $26.14 d 611,180 611,180.00 direct

MARSHALL RANDALL - > 10% Owner

2020-07-29 S 600 $27.28 d 612,597 611,180.00 direct

MARSHALL RANDALL - > 10% Owner

2020-07-29 S 1,816 $26.03 d 613,197 611,180.00 direct

MARSHALL RANDALL - > 10% Owner

2020-07-29 S 100 $28.45 d 612,497 611,180.00 direct

MARSHALL RANDALL - > 10% Owner

2020-07-28 S 1,650 $33.79 d 615,613 615,013.00 direct

MARSHALL RANDALL - > 10% Owner

2020-07-28 S 14,243 $30.42 d 621,956 615,013.00 direct

MARSHALL RANDALL - > 10% Owner

2020-07-28 S 1,200 $33.09 d 617,263 615,013.00 direct

MARSHALL RANDALL - > 10% Owner

2020-07-28 S 1,811 $28.63 d 636,199 615,013.00 direct

MARSHALL RANDALL - > 10% Owner

2020-07-28 S 600 $35.45 d 615,013 615,013.00 direct

MARSHALL RANDALL - > 10% Owner

2020-07-28 S 3,493 $31.53 d 618,463 615,013.00 direct

MARSHALL RANDALL - > 10% Owner

2020-07-28 S 2,600 $26.85 d 638,010 615,013.00 direct

MARSHALL RANDALL - > 10% Owner

2020-07-27 S 338 $26.08 d 640,610 615,013.00 direct

MARSHALL RANDALL - > 10% Owner

2020-07-24 S 300 $26.00 d 640,948 640,948.00 direct

FLANNELLY BARRY P - Director

2020-07-23 A 8,250 a 26,250 0.00 direct

MARSHALL RANDALL - > 10% Owner

2020-07-23 S 93 $27.29 d 641,248 640,948.00 direct

FLANNELLY BARRY P - Director

2020-07-23 A 18,000 a 18,000 0.00 direct

MARSHALL RANDALL - > 10% Owner

2020-07-23 S 1,950 $26.58 d 641,341 640,948.00 direct

MARSHALL RANDALL - > 10% Owner

2020-07-22 S 75 $27.45 d 643,291 643,291.00 direct

MARSHALL RANDALL - > 10% Owner

2020-07-22 S 1,297 $26.69 d 643,366 643,291.00 direct

MARSHALL RANDALL - > 10% Owner

2020-07-21 S 223 $26.56 d 644,663 643,291.00 direct

MARSHALL RANDALL - > 10% Owner

2020-07-20 S 472 $27.68 d 644,886 644,886.00 direct

MARSHALL RANDALL - > 10% Owner

2020-07-20 S 2,257 $26.70 d 645,358 644,886.00 direct

MARSHALL RANDALL - > 10% Owner

2020-07-17 S 1,601 $26.66 d 647,615 644,886.00 direct

MARSHALL RANDALL - > 10% Owner

2020-07-13 S 2,145 $27.13 d 649,216 649,216.00 direct

SHEFFERMAN JESSE - Director - Officer CEO AND PRESIDENT

2020-07-10 A 111,250 a 111,250 0.00 direct

MARSHALL RANDALL - > 10% Owner

2020-07-10 S 2,659 $27.41 d 651,361 649,216.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments